Prevent an increase in the proportion of nontyphoidal Salmonella infections that are resistant to multiple drug classes — Data - Healthy People 2030

National Status: Baseline only

Most Recent Data:
9.3 percent (2016-18)

National Target:
9.3 percent ¹

Desired Direction:
Maintains

National Baseline:
9.3 percent of nontyphoidal Salmonella infections in humans were resistant to 3 or more drug classes in 2016-18 ²

Locality

Demographic Group

From (year)

To (year)

Show disparities data

Show confidence interval (CI) View CI in the chart by hovering over a data point.

Show standard error (SE) View SE in the chart by hovering over a data point.

Confidence Interval (CI) not available Standard Error (SE) not available Confidence Interval (CI) and Standard Error (SE) are not available

Display data for:

Population	2016-18
Total	9.3 CI 8.7 / 10.0 SE 0.331

Reference rate:

Data Source: National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS), CDC/NCEZID

1 Target has been revised. See Data Methodology and Measurement for more information.

2 Baseline has been revised. See Data Methodology and Measurement for more information.

#: Standard errors and confidence intervals are not available for this population group.

†: Target is not applicable for this demographic group.

DSU: Data do not meet the criteria for statistical reliability, data quality, or confidentiality.

DNA: Data have not been analyzed.

DNC: Data for specific population not collected.

--- : Data are not available.